From: Predictors of progression of multiple sclerosis in a sample of Egyptian patients
RRMS (n = 150) | SPMS (n = 150) | p-value | |||
---|---|---|---|---|---|
No. | % | No. | % | ||
Relapse before starting DMDs | |||||
Brainstem | 19 | 12.7 | 29 | 19.3 | 0.115 |
Cerebellar | 26 | 17.3 | 72 | 48 | < 0.001* |
Motor | 61 | 40.7 | 39 | 26 | 0.007* |
Sensory | 6 | 4 | 12 | 8 | 0.145 |
Spinal | 53 | 35.3 | 98 | 65.3 | < 0.001* |
Vision | 66 | 44 | 62 | 41.3 | 0.64 |
Relapses no., Mean ± SD | 1.67 ± 0.7 | 3.13 ± 2.1 | < 0.001*m | ||
Number of lesions | < 0.001* | ||||
1–5 | 32 | 21.3 | 8 | 5.3 | |
6–10 | 73 | 48.7 | 54 | 36 | |
> 10 | 45 | 30 | 88 | 58.7 | |
Enhanced lesions | < 0.001* | ||||
1–3 | 79 | 52.7 | 59 | 39.3 | |
> 3 | 43 | 28.6 | 85 | 56.7 | |
Not present | 28 | 18.7 | 6 | 4 | |
Site of lesion PV | 150 | 100 | 150 | 100 | NA |
Site of lesion JC | 69 | 46 | 109 | 72.7 | < 0.001* |
Site of lesion IT | 118 | 78.7 | 139 | 92.7 | < 0.001*f |
Spinal lesions number | < 0.001* | ||||
1 | 78 | 55.7 | 23 | 15.5 | |
2 | 60 | 42.9 | 46 | 31.1 | |
3 | 2 | 1.4 | 44 | 29.7 | |
4 | 0 | 0 | 27 | 18.2 | |
5 | 0 | 0 | 8 | 5.4 | |
Visual involvement | 0.33 | ||||
ND | 74 | 49.3 | 69 | 46 | |
Normal | 20 | 13.3 | 14 | 9.3 | |
Prolonged | 56 | 37.3 | 67 | 44.7 | |
OCB, median (IQR) | 2 (2–10) | 5 (2–10) | 0.024*m | ||
Black holes | |||||
< 3 | 33 | 22 | 29 | 19.3 | |
> 5 | 12 | 8 | 53 | 35.3 | < 0.001* |
3_5 | 27 | 18 | 46 | 30.7 | |
Not present | 78 | 52 | 21 | 14 |